摘要
Hepatocellular carcinoma (HCC) is known as the fifth most common cancer in the world for its poor prognosis. New diagnostic markers and treatments are urgent to discover. To evaluate the protein expression of Tropomyosin4 (TPM4) and investigate its prognostic value in HCC, we collected 110 patients with different degrees of HCC and 10 patients with normal hepatic tissues and performed immunohistochemistry. Western bot was used to evaluate the expression of TPM4 in three HCC cell lines (HepG2, Huh7, SMMC-7721) and normal liver cell line LO2, as well as 7 HCC tissues and 7 normal hepatic tissues. The results of TPM4 staining revealed that TPM4 expression in HCC was higher than that in normal hepatic tissues, which was positive in 51.8% (n=57) and negative in 48.2% (n=53) while in normal hepatic tissues positive staining was in 10% (n=1) and negative staining was in 90% (n=9) (P=0.011). And the expression of TPM4 was related to pT status, grade and stage (P<0.001, P=0.015 and P<0.001, respectively). Western blot results indicated that TPM4 was high expressed in HCC cell line and HCC tissues. In conclusion, we believe that TPM4 can be applied as a diagnostic and prognostic marker to assist the management of HCC.
学科与关键词
- Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinomaZheng, Ruinian; Lai, Guowei; Li, Rongfa; Hao, Yanyan; Cai, Limin*; Jia, Jun*Journal of Gastrointestinal Oncology, 2021, 12(1): 153-173.被引 7
- MACC1 as a Prognostic Biomarker for Early-Stage and AFP-Normal Hepatocellular CarcinomaXie Chan; Wu Jueheng; Yun Jingping; Lai Jiaming; Yuan Yunfei; Gao Zhiliang; Li Mengfeng; Li Jun; Song Libing*PLoS ONE, 2013, 8(5): e64235.被引 17
- EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinomaLi, Linjing*; Li, Xin; Zhang, Qingyan; Ye, Tao; Zou, Shuli; Yan, JingAmerican Journal of Cancer Research, 2021, 12(16): 4774-4779.被引 5
